Dysregulated JNK signalling is implicated in the pathophysiology of PD [160] and AD [161], by facilitating dopaminergic neuronal death and modulating the activity of p53 upregulated modulator of apoptosis (PUMA), respectively [162]. This evidence concerns the gene MAPK8 and Alzheimer disease.